In AD, the decrease of MUC2 may lead to a loss of protective effect and AD [48], while on the contrary, the overexpression of MUC2 may also lead to oncogenic effects by decreasing the innate and adaptive immune response with the appearance of increasing mucin secretion [49]. Here, MUC2 is linked to Alzheimer disease.